Program

TBA

Keynotes

Lodewyk Wessels, PhD
Professor in Molecular Carcinogenesis Division, Netherlands Cancer Institute
Presentation Title: Molecular networks as determinants of response and outcome

Abstract: Precision medicine requires the mapping of clinical and molecular variables to response to (combination) treatment. The exact mechanisms involved in tumor development and therapy response, however, are still largely unclear. Here we report on two computational approaches we developed to systematically unravel these mechanisms based on high throughput datasets, and show these can be employed to predict response to anti-cancer agents. Our results obtained on the TCGA pan-cancer data and the GDSC1000 cell line drug screen bring precision medicine a step closer.

Short Bio: Prof. Lodewyk Wessels is the head of the Computational Cancer Biology group at the Netherlands Cancer Institute in Amsterdam, The Netherlands. His group focuses on developing novel computational approaches to exploit a wide variety of data sources to map out the cancer landscape, unravel its regulation and employ this knowledge the develop strategies for personalized treatment. Dr Wessels received his M.Sc. and Ph.D. both from the Department of Electronic and Computer Engineering, University of Pretoria, South Africa. From 1993 to 1997 he was a member of the Center for Spoken Language Understanding at the Oregon Graduate School of Science and Technology. In 1997 he joined the Faculty of Electrical Engineering, Mathematics and Computer Science at the Delft University of Technology and was appointed assistant professor in 2002. In 2006 he became a faculty member at the Netherlands Cancer Institute in Amsterdam, The Netherlands. He was appointed chair of Computational Cancer Biology at the Delft University of Technoilogy in 2012 and in 2016 as Deputy Director Research of the Netherlands Cancer Institute

Cesare Furlanello, PhD
Head of Predictive Models for Biomedicine & Environment, Fondazione Bruno Kessler, Italy
Presentation Title: TBA

The scientific program includes keynotes by leading researchers in the field and selected presentations of contest dataset analyses. The two-day meeting will also feature a social dinner with and opportunities for informal discussions. The conference will close on Saturday in time for delegates to join to the evening reception of ISMB.
Sign up to our low-volume CAMDA 2017 announcements mailing list!
https://twitter.com/camda_conf Follow us in twitter

PAST KEYNOTE SPEAKERS

Atul Butte, MD, PhD
Atul Butte, MD, PhD
Stanford University School of Medicine

Nikolaus Rajewsky, PhD
Nikolaus Rajewsky, PhD
Max-Delbrück-Center for Molecular Medicine

Terry Speed, PhD
Terry Speed, PhD
The Walter and Eliza Hall Institute of Medical Research

Sandrine Dupoit, PhD
Sandrine Dudoit, PhD
University of California, Berkeley

John Quackenbush, PhD
John Quackenbush, PhD
Harvard School of Public Health

Eran Segal, PhD
Eran Segal, PhD
Weizmann Institute of Science

John Storey, PhD
John Storey, PhD
Princeton University

Chris Sander, PhD
Chris Sander, PhD
Memorial Sloan Kettering Cancer Center

Temple F. Smith, PhD
Temple F. Smith, PhD
Boston University

Curtis Huttenhower, PhD
Curtis Huttenhower, PhD
Harvard School of Public Health

Christopher E. Mason, PhD
Christopher E. Mason, PhD
Weill Cornell Medicine

Mick Watson, PhD
Mick Watson, PhD
The Roslin Institute

IMPORTANT DATES
Extended Abstract Proposals Due19 May 2017
Notification of Accepted Contributions26 May 2017
Early Registration Closes15 Jun 2017
CAMDA2017 Conference22-23 Jul 2017
ISMB/ECCB 2017 Conference21–25 Jul 2017
Full Paper Submission Click to save the dates!24 Sep 2017
CAMDA PARTNERS

Agilent Technologies

F1000Research

Biology Direct

ISMB/ECCB 2017 MAIN EVENT
STAY CONNECTED